Viewing Study NCT05970705


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2025-12-26 @ 2:10 AM
Study NCT ID: NCT05970705
Status: RECRUITING
Last Update Posted: 2023-08-01
First Post: 2023-07-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module